 Visit Bulgaria |
Theravance Falls Most in 3 Years After Glaxo Drug Fails
BusinessWeek The company, based in South San Francisco, California, said in a statement today that Relovair, its drug for asthma and chronic obstructive pulmonary disease, proved no better than Glaxo's Seretide in a clinical trial. Relovair is “the most important … GSK and Theravance Announce Initial Outcomes From Pivotal Phase III Studies … Glaxo on the slide after trials setback for asthma drug Theravance Shares Slide on Lung Drug Deaths |
View full post on asthma – Google News